A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma

Despite numerous clinical trials and pre-clinical developments, the treatment of glioblastoma (GB) remains a challenge. The current survival rate of GB averages one year, even with an optimal standard of care. However, the future promises efficient patient-tailored treatments, including targeted rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolcaen, Julie, Kleynhans, Janke, Nair, Shankari, Verhoeven, Jeroen, Goethals, Ingeborg, Sathekge, Mike, Vandevoorde, Charlot, Ebenhan, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315062/
https://www.ncbi.nlm.nih.gov/pubmed/34335972
http://dx.doi.org/10.7150/thno.56639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315062/
https://www.ncbi.nlm.nih.gov/pubmed/34335972
http://dx.doi.org/10.7150/thno.56639

Ejemplares similares